Hemostasis of Left Atrial Appendage Bleed With Lariat Device

New devices designed for minimally invasive closure of the left atrial appendage (LAA) may be a viable alternative for patients in whom anticoagulation is considered high risk. The Lariat (Sentreheart, Redwood City, CA), which is currently FDA-approved for percutaneous closure of tissue, requires bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Amena, Saric, Muhamed, Bernstein, Scott, Holmes, Douglas, Chinitz, Larry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Indian Heart Rhythm Society 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217304/
https://www.ncbi.nlm.nih.gov/pubmed/25408569
_version_ 1782342376831844352
author Hussain, Amena
Saric, Muhamed
Bernstein, Scott
Holmes, Douglas
Chinitz, Larry
author_facet Hussain, Amena
Saric, Muhamed
Bernstein, Scott
Holmes, Douglas
Chinitz, Larry
author_sort Hussain, Amena
collection PubMed
description New devices designed for minimally invasive closure of the left atrial appendage (LAA) may be a viable alternative for patients in whom anticoagulation is considered high risk. The Lariat (Sentreheart, Redwood City, CA), which is currently FDA-approved for percutaneous closure of tissue, requires both trans-septal puncture and epicardial access. However it requires no anticoagulation after the procedure. Here we describe a case of effusion and tamponade during a Lariat procedure with successful completion of the case and resolution of the effusion.
format Online
Article
Text
id pubmed-4217304
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Indian Heart Rhythm Society
record_format MEDLINE/PubMed
spelling pubmed-42173042014-11-18 Hemostasis of Left Atrial Appendage Bleed With Lariat Device Hussain, Amena Saric, Muhamed Bernstein, Scott Holmes, Douglas Chinitz, Larry Indian Pacing Electrophysiol J Case Report New devices designed for minimally invasive closure of the left atrial appendage (LAA) may be a viable alternative for patients in whom anticoagulation is considered high risk. The Lariat (Sentreheart, Redwood City, CA), which is currently FDA-approved for percutaneous closure of tissue, requires both trans-septal puncture and epicardial access. However it requires no anticoagulation after the procedure. Here we describe a case of effusion and tamponade during a Lariat procedure with successful completion of the case and resolution of the effusion. Indian Heart Rhythm Society 2014-10-06 /pmc/articles/PMC4217304/ /pubmed/25408569 Text en Copyright: © 2014 Hussain et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Hussain, Amena
Saric, Muhamed
Bernstein, Scott
Holmes, Douglas
Chinitz, Larry
Hemostasis of Left Atrial Appendage Bleed With Lariat Device
title Hemostasis of Left Atrial Appendage Bleed With Lariat Device
title_full Hemostasis of Left Atrial Appendage Bleed With Lariat Device
title_fullStr Hemostasis of Left Atrial Appendage Bleed With Lariat Device
title_full_unstemmed Hemostasis of Left Atrial Appendage Bleed With Lariat Device
title_short Hemostasis of Left Atrial Appendage Bleed With Lariat Device
title_sort hemostasis of left atrial appendage bleed with lariat device
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217304/
https://www.ncbi.nlm.nih.gov/pubmed/25408569
work_keys_str_mv AT hussainamena hemostasisofleftatrialappendagebleedwithlariatdevice
AT saricmuhamed hemostasisofleftatrialappendagebleedwithlariatdevice
AT bernsteinscott hemostasisofleftatrialappendagebleedwithlariatdevice
AT holmesdouglas hemostasisofleftatrialappendagebleedwithlariatdevice
AT chinitzlarry hemostasisofleftatrialappendagebleedwithlariatdevice

Ejemplares similares